Showing results (241-250 of 351) with videos related to

Sort By:
Pageof 36
The Lancet Regional Health. Europe|September 22, 2025
Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyMaria Angeliki Toli, Xingrong Liu, Davide Massa, et al.
Nature Communications|May 7, 2024
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancerKang Wang, Ioannis Zerdes, Henrik J Johansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progressionLinda Sofie Lindström, Eva Karlsson, Ulla M Wilking, et al.
NPJ Breast Cancer|July 1, 2026
AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancerDusan Rasic, Sandra Sinius Pouplier, Maj-Britt Jensen, et al.
Breast Cancer Research and Treatment|December 10, 2024
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohortGudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, et al.
Breast Cancer Research : BCR|January 3, 2024
Identification of a Notch transcriptomic signature for breast cancerEike-Benjamin Braune, Felix Geist, Xiaojia Tang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2012
Evidence of a functional estrogen receptor in parathyroid adenomasFelix Haglund, Ran Ma, Mikael Huss, et al.
Endocrine Connections|February 5, 2015
Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weightFelix Haglund, Gustaf Rosin, Inga-Lena Nilsson, et al.
Pageof 36